# OnCo record lp-184 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/lp-184/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "lp-184" ;
  schema:name "LP-184"@en ;
  schema:description "LP-184 is a small-molecule inhibitor from Lantern Pharma Inc., in registered phase 2 trials for triple-negative breast cancer, non-small-cell lung cancer, pancreatic ductal adenocarcinoma."@en ;
  schema:url <https://onco.cc/drugs/lp-184/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=LP-184> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest", "registry-only" ;
  onco:modality "Small-molecule inhibitor" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:companies <https://onco.cc/companies/lantern-pharma/> ;
  onco:trials <https://onco.cc/trials/nct05933265/> .